Patients taking dual antiplatelet therapy have a high frequency of minor hemorrhage and should be taught to anticipate and recognize such events, according to the results of a large, retrospective analysis reported in the Nov. 22 issue of Archives of Internal Medicine. Otherwise, patients caught unawares may overreact to minor hemorrhage and discontinue the antiplatelet therapy abruptly, jeopardizing their health, wrote Nadine Shehab, Pharm.D., of the Centers for Disease Control and Prevention, Atlanta,...